Clinical trial
A Randomized, Controlled, Open-Label Study to Investigate the Effect of NGX-4010 on Epidermal Nerve Fiber Density and Sensory Function in Healthy Volunteers
NCT00254449 is registered in ClinicalTrials.gov with NeurogesX as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Controlled, Open-Label Study to Investigate the Effect of NGX-4010 on Epidermal Nerve Fiber Density and Sensory Function in Healthy Volunteers
- Lead sponsor
- NeurogesX
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- November 30, 2005
- Completion date
- May 31, 2006
- Enrollment
- 36
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
human volunteers